Canada Life’s Kite Pharma, Inc. KITE Stock Holding History

Canada Life’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,013	Closed	-$899K	–	2613
2017 Q3	$899K	Hold	5,013	–	–	﹤0.01%	1554
2017 Q2	$519K	Hold	5,013	–	–	﹤0.01%	1703
2017 Q1	$392K	Buy	5,013 +1,100	+28%	+$68K	﹤0.01%	1767
2016 Q4	$176K	Hold	3,913	–	–	﹤0.01%	1946
2016 Q3	$218K	Hold	3,913	–	–	﹤0.01%	1885
2016 Q2	$195K	Hold	3,913	–	–	﹤0.01%	1897
2016 Q1	$179K	Hold	3,913	–	–	﹤0.01%	1384
2015 Q4	$241K	Buy	3,913 +1,565	+67%	+$110K	﹤0.01%	1192
2015 Q3	$131K	Hold	2,348	–	–	﹤0.01%	1513
2015 Q2	$143K	Hold	2,348	–	–	﹤0.01%	1597
2015 Q1	$135K	Buy	+2,348	New	+$157K	﹤0.01%	1599

Canada Life's KITE Position: Q4 2017 in Review

Canada Life sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 5,013 shares — an estimated $899K sold.

Canada Life first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $899K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Canada Life reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Canada Life sold 5,013 Kite Pharma, Inc. shares in Q4 2017, an estimated $899K.
Canada Life first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
Canada Life's Kite Pharma, Inc. position peaked at $899K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Canada Life's 13F filing for Q4 2017, filed 9 Feb 2018.